microbiome Archives - Bio-Me

Bio-Me has been selected as one of the newest companies to join Nordic Mentor Network For Entrepreneurship – NOME

Ana Finzel — Wed, 12 Aug 2026 10:28:48 +0000

Bio-Me has been selected to join the Nordic Mentor Network For Entrepreneurship (NOME), gaining access to a network of experienced life science mentors as it scales its Precision Microbiome Profiling (PMP™) platform and explores new applications in women's health and reproductive care. Read More

The post Bio-Me has been selected as one of the newest companies to join Nordic Mentor Network For Entrepreneurship – NOME appeared first on Bio-Me.

Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk

Ana Finzel — Thu, 07 Sep 2023 08:52:22 +0000

The PREVALUNG EU program aims to implement cancer risk stratification tools and personalized interventions to intercept lung cancer in cardiovascular patients. Bio-Me’s Precision Microbiome Profiling (PMP™) was chosen for high-throughput gut microbiome profiling. Read More

The post Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk appeared first on Bio-Me.

Bio-Me’s technology used for identifying bacteria associated with appendicular lean mass in a Nature Communications publication

Ana Finzel — Thu, 27 Apr 2023 08:57:50 +0000

PMP™ was used in a recent study to identify gut microbial species that are directly associated with appendicular lean mass and bone mineral density. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™. Read More

The post Bio-Me’s technology used for identifying bacteria associated with appendicular lean mass in a Nature Communications publication appeared first on Bio-Me.

Bio-Me´s PMP™ platform demonstrates its diagnostic and prognostic applicability in pediatric IBD

Jon Eriksen — Fri, 05 Aug 2022 10:23:00 +0000

PMP™ was used in a recent study to explore the gut microbiome of children with inflammatory bowel disease (IBD), symptomatic non-IBD, and healthy children. Diagnostic, Phenotype and Prognostic Indexes were constructed based on PMP™ data with very good discriminating properties. Read More

The post Bio-Me´s PMP™ platform demonstrates its diagnostic and prognostic applicability in pediatric IBD appeared first on Bio-Me.

Bio-Me strengthens its international commercial team with key hire

Jon Eriksen — Mon, 04 Jul 2022 09:28:33 +0000

Bio-Me has employed Dr. Anne-Grethe Reichelt as part of the company’s plan to widen commercial adoption of their existing product portfolio and launch new products under development. Read More

The post Bio-Me strengthens its international commercial team with key hire appeared first on Bio-Me.

Bio-Me Joins Medicen Working Group

Jon Eriksen — Fri, 01 Jul 2022 14:45:11 +0000

Bio-Me has joined the Medicen Working Group, an international initiative focusing on drug-microbiome interactions. The aim of the group is to accelerate the microbiome integration in the drug discovery and development process. Read More

The post Bio-Me Joins Medicen Working Group appeared first on Bio-Me.

Bio-Me´s technology demonstrates its usefulness in metabolic syndrome research in a Lancet publication

Jon Eriksen — Fri, 10 Jun 2022 06:02:33 +0000

PMP™ has shown its applicability in obesity research in a study published in The Lancet. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™. Read More

The post Bio-Me´s technology demonstrates its usefulness in metabolic syndrome research in a Lancet publication appeared first on Bio-Me.

Bio-Me Joins Microbiome Therapeutics Innovation Group

Jon Eriksen — Tue, 26 Apr 2022 09:21:21 +0000

Bio-Me has joined MTIG. Group members work together to accelerate microbiome-based drug development and expand availability of approved microbiome therapies to patients. Read More

The post Bio-Me Joins Microbiome Therapeutics Innovation Group appeared first on Bio-Me.

Dr. Warren Flood steps up as CEO of Bio-Me

Jon Eriksen — Wed, 02 Mar 2022 10:26:37 +0000

Bio-Me has appointed a new CEO as part of the company’s strategic plan to be positioned as a leader in the microbiome-based Precision Medicine space. Read More

The post Dr. Warren Flood steps up as CEO of Bio-Me appeared first on Bio-Me.

Joint webinar of Thermo Fisher Scientific and Bio-Me on September 22nd with focus on how the PMP™ technology can support researchers and industry

Jon Eriksen — Wed, 08 Sep 2021 14:43:56 +0000

Our COO, Warren Flood, will be participating in a webinar together with Thermo Fisher Scientific on September 22nd with a focus on our PMP™ technology and its applicability. Read More

The post Joint webinar of Thermo Fisher Scientific and Bio-Me on September 22nd with focus on how the PMP™ technology can support researchers and industry appeared first on Bio-Me.